High-flux hemodialysis without hemoperfusion is effective in acute valproic acid overdose.
OBJECTIVE
To report a case of valproic acid overdose treated successfully with high-flux hemodialysis without the addition of charcoal hemoperfusion.


METHODS
A 25-year-old white woman with a history of multiple suicide attempts and schizophrenia presented after ingesting an unknown amount of valproic acid. She became comatose and developed hypotension and lactic acidosis as valproic acid concentrations increased to > 1200 micrograms/mL (therapeutic concentration 50-100). High-flux hemodialysis was performed for four hours; the calculated elimination rate constant (kel) during the procedure was 0.2522 h-1 with a half-life (t1/2) of 2.74 hours compared with posthemodialysis kel of 0.0296 h-1 and t1/2 of 23.41 hours, suggesting that high-flux hemodialysis effectively eliminates valproic acid. The patient's hemodynamic status and mental function improved in conjunction with the acute reduction in valproic acid concentrations. Her subsequent hospital course was complicated only by transient thrombocytopenia.


CONCLUSIONS
Most literature reports of valproic acid overdose have described the use of charcoal hemoperfusion alone or in combination with hemodialysis to accelerate valproic acid clearance at toxic concentrations. However, the pharmacokinetic properties of valproic acid indicate that hemodialysis alone would be effective therapy for an acute valproic acid overdose.


CONCLUSIONS
We suggest that toxic concentrations of valproic acid can be effectively reduced with high-flux hemodialysis without the addition of charcoal hemoperfusion and its attendant risks.
Kane
S L
SL
College of Pharmacy, Ohio State University, Columbus 43210, USA. kane.80@osu.edu
Constantiner
M
M
Staubus
A E
AE
Meinecke
C D
CD
Sedor
J R
JR
D000140:Acidosis, Lactic / Q000139:chemically induced; D000328:Adult; D000465:Algorithms; D000927:Anticonvulsants / Q000097:blood / Q000506:poisoning*; D062787:Drug Overdose / Q000628:therapy*; D005260:Female; D006207:Half-Life; D006439:Hemodynamics / Q000187:drug effects; D006464:Hemoperfusion; D006801:Humans; D006435:Renal Dialysis; D012559:Schizophrenia / Q000150:complications; D013406:Suicide, Attempted; D014635:Valproic Acid / Q000097:blood / Q000506:poisoning*
D000927:Anticonvulsants; D014635:Valproic Acid